| Literature DB >> 35456848 |
Sornsiri Pattanakittivorakul1, Tatsuya Tsuzuno2, Tomoyuki Kosaka1,2,3, Masayuki Murata3, Yu Kanesaki4, Hirofumi Yoshikawa5, Savitree Limtong6, Mamoru Yamada1,2,3.
Abstract
During ethanol fermentation, yeast cells are exposed to various stresses that have negative effects on cell growth, cell survival, and fermentation ability. This study, therefore, aims to develop Kluyveromyces marxianus-adapted strains that are multi-stress tolerant and to increase ethanol production at high temperatures through a novel evolutionary adaptation procedure. K. marxianus DMKU 3-1042 was subjected to repetitive long-term cultivation with gradual increases in temperature (RLCGT), which exposed cells to various stresses, including high temperatures. In each cultivation step, 1% of the previous culture was inoculated into a medium containing 1% yeast extract, 2% peptone, and 2% glucose, and cultivation was performed under a shaking condition. Four adapted strains showed increased tolerance to ethanol, furfural, hydroxymethylfurfural, and vanillin, and they also showed higher production of ethanol in a medium containing 16% glucose at high temperatures. One showed stronger ethanol tolerance. Others had similar phenotypes, including acetic acid tolerance, though genome analysis revealed that they had different mutations. Based on genome and transcriptome analyses, we discuss possible mechanisms of stress tolerance in adapted strains. All adapted strains gained a useful capacity for ethanol fermentation at high temperatures and improved tolerance to multi-stress. This suggests that RLCGT is a simple and efficient procedure for the development of robust strains.Entities:
Keywords: K. marxianus DMKU 3-1042; evolutionarily adapted mutants; genomic and transcriptomic analyses; multi-stress tolerance; repetitive long-term cultivation with gradual increases in temperature (RLCGT); thermotolerant ethanol-fermenting yeast
Year: 2022 PMID: 35456848 PMCID: PMC9032449 DOI: 10.3390/microorganisms10040798
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
Figure 1Growth, CFU, and fermentation parameters of K. marxianus DMKU 3-1042 in YPD medium at 30 °C and 45 °C. Cells were cultivated in YPD medium at 30 °C (●) and 45 °C (▲) under a shaking condition at 160 rpm for 7 days. Growth (a) was determined by measuring OD660. CFUs (b) were determined by counting colonies on YPD plates incubated at 30 °C. pH (c) was measured by using a twin pH meter. Glucose (d), ethanol (e), and acetate (f) were determined by HPLC. Error bars represent ±SD of values from experiments performed in triplicate.
Figure 2Fermentation of adapted strains in YP medium containing 16% glucose at high temperatures. Wild-type (✕), ACT001 (●), ACT002 (▲), ACT003 (■), and TML001 (◯) strains were cultivated in YP medium containing 16% glucose at 40–47 °C under a shaking condition at 100 rpm, and samples were taken every 8 h until 48 h. Growth was determined by measuring OD660. Glucose, ethanol, and acetate were determined by HPLC. Error bars represent ±SD of values from experiments performed in triplicate.
Comparison of growth and fermentation parameters among various adapted strains and previously reported strains.
| Strains | Temp. (°C) | Medium | Cultivation Time (h) | Growth (OD660) | Remaining | Acetic Acid | Ethanol | Increased | Ethanol Productivity | Ethanol Yield | Ref |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Wild-type | 40 | YP + 160 g L−1 glucose | 24 | 19.0 ± 0.8 | 50.1 ± 1.2 | 1.7 ± 0.1 | 49.6 ± 0.7 | - | 2.1 ± 0.0 | 0.3 ± 0.0 | This study |
| ACT001 | 40 | YP + 160 g L−1 glucose | 24 | 19.4 ± 0.7 | 7.3 ± 2.4 | 1.5 ± 0.1 | 69.7 ± 0.7 | 40 | 2.9 ± 0.0 | 0.4 ± 0.0 | This study |
| ACT002 | 40 | YP + 160 g L−1 glucose | 24 | 20.3 ± 1.2 | 5.8 ± 2.0 | 1.5 ± 0.0 | 68.5 ± 0.7 | 38 | 2.9 ± 0.0 | 0.4 ± 0.0 | This study |
| ACT003 | 40 | YP + 160 g L−1 glucose | 24 | 20.7 ± 1.0 | 8.1 ± 0.4 | 1.5 ± 0.0 | 70.3 ± 0.7 | 42 | 2.9 ± 0.0 | 0.4 ± 0.0 | This study |
| TML001 | 40 | YP + 160 g L−1 glucose | 24 | 20.7 ± 0.9 | 61.5 ± 0.4 | 1.3 ± 0.1 | 46.9 ± 0.7 | 0 | 2.0 ± 0.1 | 0.3 ± 0.0 | This study |
| Wild-type | 42 | YP + 160 g L−1 glucose | 24 | 19.6 ± 1.1 | 31.2 ± 2.2 | 1.7 ± 0.1 | 56.1 ± 1.1 | - | 2.3 ± 0.1 | 0.4 ± 0.0 | This study |
| ACT001 | 42 | YP + 160 g L−1 glucose | 24 | 17.5 ± 1.3 | 11.3 ± 1.1 | 1.4 ± 0.0 | 67.6 ± 0.3 | 20 | 2.8 ± 0.0 | 0.4 ± 0.0 | This study |
| ACT002 | 42 | YP + 160 g L−1 glucose | 24 | 17.5 ± 0.9 | 8.7 ± 1.4 | 1.5 ± 0.0 | 67.9 ± 1.2 | 21 | 2.8 ± 0.0 | 0.4 ± 0.0 | This study |
| ACT003 | 42 | YP + 160 g L−1 glucose | 24 | 17.0 ± 0.8 | 8.8 ± 1.4 | 1.5 ± 0.0 | 66.2 ± 1.0 | 18 | 2.8 ± 0.0 | 0.4 ± 0.0 | This study |
| TML001 | 42 | YP + 160 g L−1 glucose | 24 | 17.9 ± 1.2 | 29.0 ± 0.8 | 1.3 ± 0.0 | 58.1 ± 0.4 | 3 | 2.4 ± 0.0 | 0.4 ± 0.0 | This study |
| Wild-type | 45 | YP + 160 g L−1 glucose | 24 | 12.1 ± 0.6 | 59.5 ± 4.0 | 1.6 ± 0.0 | 45.5 ± 1.8 | - | 1.9 ± 0.1 | 0.3 ± 0.0 | This study |
| ACT001 | 45 | YP + 160 g L−1 glucose | 24 | 11.3 ± 0.5 | 44.5 ± 2.0 | 1.4 ± 0.0 | 54.5 ± 3.0 | 20 | 2.3 ± 0.1 | 0.3 ± 0.0 | This study |
| ACT002 | 45 | YP + 160 g L−1 glucose | 24 | 11.9 ± 1.0 | 42.8 ± 1.6 | 1.4 ± 0.0 | 56.2 ± 1.8 | 23 | 2.3 ± 0.1 | 0.4 ± 0.0 | This study |
| ACT003 | 45 | YP + 160 g L−1 glucose | 24 | 11.6 ± 0.6 | 41.4 ± 1.6 | 1.4 ± 0.1 | 55.4 ± 2.0 | 22 | 2.3 ± 0.1 | 0.4 ± 0.0 | This study |
| TML001 | 45 | YP + 160 g L−1 glucose | 24 | 12.2 ± 0.7 | 52.9 ± 2.3 | 1.4 ± 0.0 | 50.3 ± 1.7 | 11 | 2.1 ± 0.1 | 0.3 ± 0.0 | This study |
| Wild-type | 47 | YP + 160 g L−1 glucose | 32 | 9.3 ± 1.1 | 78.9 ± 1.6 | 1.9 ± 0.1 | 39.5 ± 2.8 | - | 1.2 ± 0.1 | 0.3 ± 0.0 | This study |
| ACT001 | 47 | YP + 160 g L−1 glucose | 32 | 8.9 ± 0.9 | 57.8 ± 1.4 | 1.8 ± 0.2 | 52.6 ± 2.5 | 33 | 1.7 ± 0.1 | 0.3 ± 0.0 | This study |
| ACT002 | 47 | YP + 160 g L−1 glucose | 32 | 9.0 ± 0.7 | 60.2 ± 3.2 | 1.8 ± 0.1 | 49.0 ± 3.8 | 24 | 1.5 ± 0.1 | 0.3 ± 0.0 | This study |
| ACT003 | 47 | YP + 160 g L−1 glucose | 32 | 8.5 ± 0.5 | 63.5 ± 1.3 | 1.7 ± 0.1 | 50.2 ± 1.8 | 27 | 1.6 ± 0.1 | 0.3 ± 0.0 | This study |
| TML001 | 47 | YP + 160 g L−1 glucose | 32 | 10.0 ± 0.8 | 71.4 ± 2.0 | 1.8 ± 0.1 | 41.5 ± 1.7 | 5 | 1.3 ± 0.1 | 0.3 ± 0.0 | This study |
| 28 | Sugar juice (207.25 g L−1 sugar) | 480 | NR | 10.4 ± 0.8 | NR | 126.6 ± 5.6 | - | 0.3 | 0.6 | [ | |
| 28 | Sugar juice (207.25 g L−1 sugar) | 480 | NR | 7.0 ± 1.0 | NR | 130.0 ± 4.5 | 3 | 0.3 | 0.6 | [ | |
| 34 | YP + 300 g L−1 glucose + 50 g L−1 ethanol | 72 | NR | 31.5 | NR | 106.8 | - | 1.5 | 0.4 | [ | |
| 34 | YP + 300 g L−1 glucose + 50 g L−1 ethanol | 72 | NR | 2.1 | NR | 138.1 | 29 | 1.9 | 0.5 | [ | |
| 37 | Whey permeate | 50 | NR | 0.7 ± 0.0 | NR | 66.8 ± 0.9 | - | 1.3 ± 0.0 | 0.3 ± 0.0 | [ | |
| 37 | Whey permeate | 42 | NR | 0.8 ± 0.0 | NR | 79.3 ± 0.8 | 19 | 1.7 ± 0.1 | 0.4 ± 0.1 | [ | |
| 30 | Fermentation medium | 60 | NR | 75.7 | NR | 125.0 | - | 2.1 ± 0.0 | 0.3 | [ | |
| 30 | Fermentation medium | 60 | NR | 5.5 | NR | 145.8 | 16.6 | 2.43 ± 0.1 | 0.4 | [ | |
NR: not reported.
Figure 3Characterization of adapted strains. Growth of adapted strains on YPD agar plates with pH adjusted to 3 or supplemented with 0.3% acetic acid, 0.1% formic acid (a), 8% ethanol, 15 mM furfural, 15 mM HMF (b), 0.1% vanillin or multiple inhibitors (0.15% acetate, 7.5 mM furfural and 0.075% vanillin or 0.3% acetate, 15 mM furfural and 0.15% vanillin) (c) were compared. The plates were incubated at 30–45 °C for 48 h.
Figure 4Effects of acetic acid on growth and fermentation parameters of adapted strains at 40 °C. Adapted strains were cultivated in YPD medium supplemented with 0.2% or 0.3% acetic acid at 40 °C under a shaking condition at 160 rpm for 48 h. Growth (a) was determined by measuring OD660. Glucose (b), ethanol (c), and acetate (d) were determined by HPLC. Error bars represent ±SD of values from experiments performed in triplicate.
Summary of mutations of adapted strains.
| Adapted Strain | Gene/Locus_Tag | Product | Region | Ref | Allele | Type | Amino Acid Change |
|---|---|---|---|---|---|---|---|
| ACT001 | KLMA_10738 | PH domain-containing protein | 1552906^1552907 | - | G | Insertion | Lle812fs |
| 47658 | T | - | Deletion | Non-coding region | |||
| ACT002 | 1161817 | G | A | SNP | Non-coding region | ||
| GAL1 | Galactokinase | 712698 | G | T | SNP | Lue391Phe | |
| ALY2 | UPF0675 protein Orthologue of YJL084C | 385614 | G | A | SNP | synonymous | |
| KLMA_40563 | ATP-dependent protease La | 1269738 | T | C | SNP | synonymous | |
| ACT003 | 1107715 | T | C | SNP | Non-coding region | ||
| TML001 | FSH3 | Family of serine hydrolase 3 | 613476 | C | G | SNP | Lle253Met |
| PMA1 | Plasma membrane ATPase | 968552^968553 | - | GCT | Insertion | Ala255_Leu256insAla | |
| TNA1 | High-affinity nicotinic acid transporter | 1010140 | C | G | SNP | Phe467Leu | |
| 1714543 | G | A | SNP | Non-coding region | |||
| KLMA_40326 | Hypothetical protein | 767036 | G | T | SNP | Glu106 * | |
| 724738 | T | G | SNP | Non-coding region | |||
| SVL3 | Styryl dye vacuolar localization protein 3 | 815396 | C | A | SNP | Ser629 * |
SNPs: Single nucleotide polymorphisms; fs: frame-shift mutation; * stop codon.
Up-regulated (log2 > 1) and down-regulated (log2 < −1) genes in ACT001 strain.
| Locus_Tag | Gene | Log2 Fold Change | Product |
|---|---|---|---|
| Up-regulated | |||
| KLMA_70179 |
| 1.90 | Isocitrate lyase |
| KLMA_70444 |
| 1.43 | Citrate synthase 3 |
| KLMA_30101 |
| 1.24 | stationary phase protein 4 |
| KLMA_20819 |
| 1.20 | hypothetical protein |
| KLMA_60471 |
| 1.12 | putative subtilase-type proteinase YCR045C |
| KLMA_60452 |
| 1.08 | fructose-1,6-bisphosphatase |
| KLMA_20009 |
| 1.04 | acetate transporter |
| Down-regulated | |||
| KLMA_50379 |
| −1.99 | high-affinity potassium transporter |
| KLMA_50489 |
| −1.39 | zinc-regulated transporter 2 |
| KLMA_10655 |
| −1.37 | ATPase-coupled transporter |
| KLMA_50332 |
| −1.33 | probable transporter SEO1 |
| KLMA_10677 |
| −1.18 | protein MET17 |
| KLMA_30339 |
| −1.17 | ATP synthase subunit b |
| KLMA_30724 |
| −1.17 | pyridoxal-5′-phosphate synthase |
| KLMA_30338 |
| −1.08 | protein ICY2 |
| KLMA_60029 |
| −1.01 | acyl-CoA dehydrogenase family member 11 |
| KLMA_30726 |
| −1.00 | probable pyridoxal-5′-phosphate synthase subunit |
Each strain was performed in duplicate.